Irving Millman

Source: Wikipedia, the free encyclopedia.

Irving Millman (May 23, 1923 – April 17, 2012) was a noted

Bronze Star. In 1948, Millman earned a bachelor's degree from the City College of New York. He did his graduate work at the University of Kentucky and Northwestern University's School of Medicine.[1]

Millman's work with

Baruch Blumberg helped lead to the creation of a test to detect hepatitis B
. The test allowed blood banks to identify the hepatitis B virus in the blood of potential donors, thereby preventing the spread of the virus.

Later research by the team led to a vaccine that is now commonly given to neonates (newborns).[1] Millman and Blumberg found that the blood of individuals who carried the hepatitis B virus contained particles of the outside coating of the virus. The coating, hepatitis B surface antigen (HBsAg), is not infectious; however, HBsAG can provoke an immune response. In order to develop a vaccine, Millman and Blumberg developed a method of detaching the coatings from the virus.[2] He was Jewish.[3]

References

  1. ^ a b Donald G. McNeil, Jr., April 26, 2012, Irving Millman Dies at 88; Worked to Stop Hepatitis B, The New York Times.
  2. ^ His Hepatitis B Vaccine Saves Over 6 Million Lives [1] Accessed August 18, 2013
  3. .